RVL Pharmaceuticals
RVLP
#10128
Rank
NZ$5.55 M
Marketcap
$0.04984
Share price
-32.05%
Change (1 day)
4.58%
Change (1 year)

Revenue for RVL Pharmaceuticals (RVLP)

Revenue in 2023 (TTM): NZ$60.59 Million

According to RVL Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is NZ$65.24 Million. In 2022 the company made a revenue of NZ$78.31 Million an increase over the revenue in the year 2021 that were of NZ$59.21 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for RVL Pharmaceuticals from 2018 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) NZ$60.59 M-22.62%
2022 NZ$78.31 M32.25%
2021 NZ$59.21 M-75.98%
2020 NZ$0.24 B-30.83%
2019 NZ$0.35 B-9.34%
2018 NZ$0.39 B